Alembic gains final USFDA approval for Albendazole Tablets USP, 200 mg
Albendazole tablets are indicated for the treatment of parenchymal neurocysticercosis due to active lesions caused by larval forms…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Albendazole Tablets
Dr Reddy’s launches of AlbendazoleTablets, USP in the US market
Albendazole is an anthelmintic drug to treat parenchymal neurocysticercosis and cystic hydatid disease of the liver, lung, and…